Breaking News

Novella Clinical Names European and Asian Ops Director

By Kristin Brooks | March 11, 2014

Smyth brings more than 20 years of R&D experience

Chris Smyth, Ph.D., MBA has been appointed managing director of European and Asian operations at Novella Clinical, a Quintiles company. Dr. Smyth will be based in Novella’s European headquarters in Stevenage, England, and will provide strategic leadership, organization and training resources for the company’s regional teams. Dr. Smyth will also lead oncology delivery operations in all markets outside the U.S. He succeeds Elizabeth Edwards, who will now serve as executive vice president of global operations, overseeing Novella’s clinical monitoring division.
 
Dr. Smyth has more than 20 years of R&D experience, having led CROs and biopharma companies in Europe and the U.S., dealing exclusively in hematology and oncology drug development since 2003. He joins the company from INC Research, where he served as senior vice president of clinical development in the oncology division.
 
“We are fortunate to have someone as experienced as Dr. Smyth guiding our team and business objectives in Europe and Asia,” said Novella Clinical Chief Operating Officer Rob King. “His depth of international leadership and oncology operations expertise will prove to be an invaluable resource as we continue to expand our services into new markets.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important